Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor-Positive Breast Cancer: Clinical Versus Molecular Tools

J Clin Oncol. 2019 Jun 1;37(16):1365-1369. doi: 10.1200/JCO.18.01933. Epub 2019 Apr 3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy*
  • Clinical Decision-Making
  • Disease Progression
  • Disease-Free Survival
  • Female
  • Humans
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local*
  • Neoplasm Staging
  • Patient Selection
  • Receptors, Estrogen / metabolism*
  • Risk Assessment
  • Risk Factors
  • Time Factors

Substances

  • Biomarkers, Tumor
  • Receptors, Estrogen